Insider Sales at Sophia Genetics Show Routine Rebalancing, Not Confidence Loss
Insider sales at Sophia Genetics SA reveal routine portfolio rebalancing amid a robust 59% YTD gain, highlighting the company’s strategic cloud‑diagnostics growth and market‑compliant outlook.
4 minutes to read